Retractable Technologies RVP
NYSE RVP
$0.71 +0.00 (+0.59%)
As of: Sep 9, 2026 · 12:57 PM EDT

Retractable Technologies (RVP) Income from Continuing Operations (2010 - 2026)

Retractable Technologies' (RVP) quarterly Income from Continuing Operations came in at $2.2 million in Q2 2026, up 2658.29% on a YoY basis from $81128.6 in Q2 2025, and up 166.98% quarter-over-quarter from -$3.3 million in Q1 2026.

Analysis

Retractable Technologies (RVP) Income from Continuing Operations (2010 - 2026) Analysis & Trends

Retractable Technologies (RVP) has reported Income from Continuing Operations for 17 consecutive years, with $2.2 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Income from Continuing Operations rose 2658.29% year-over-year to $2.2 million; the trailing twelve-month figure through Jun 2026 stood at -$211304.0 (up 97.58% YoY), and the FY2025 full-year result was -$9.7 million, up 18.43% from the prior year.
  • Income from Continuing Operations advanced to $2.2 million in Q2 2026 per RVP's latest filing, from -$3.3 million in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at $7.6 million in Q1 2022 and bottomed at -$14.2 million in Q2 2024.
  • Historically, Income from Continuing Operations has averaged -$959518.0 across 5 years, with a median of $149050.5 in 2023.
  • The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations soared 5269.2% in 2024, then plunged 2545.53% in 2025.
  • Over 5 years, Income from Continuing Operations stood at $3.1 million in 2022, then sank by 102.38% to -$72946.0 in 2023, then jumped by 5269.2% to $3.8 million in 2024, then tumbled by 86.19% to $520729.0 in 2025, then soared by 329.74% to $2.2 million in 2026.
  • According to Business Quant data, Income from Continuing Operations over the past three periods registered $2.2 million, -$3.3 million, and $520729.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Becton Dickinson 49.48 Bn 48.62 Bn 2.32 Bn 452.00 Mn
2 Medline 29.24 Bn 26.56 Bn 2.22 Bn 139.00 Mn
3 West Pharmaceutical Services 23.94 Bn 23.51 Bn 329.20 Mn 147.90 Mn
4 Baxter International 12.66 Bn 10.51 Bn 1.03 Bn 135.00 Mn
5 Stevanato Group S.p.A 5.51 Bn 5.40 Bn 100.91 Mn 26.68 Mn
6 Acme United 233.67 Mn 228.63 Mn 26.69 Mn 5.05 Mn
7 Rockwell Medical 31.87 Mn 7.07 Mn 3.24 Mn -1.30 Mn
8 Retractable Technologies 21.39 Mn -18.48 Mn 190,852.00 2.24 Mn
9 United Health Products 9.09 Mn 9.06 Mn - -217,306.00
10 Cuprina Holdings (Cayman) 7.45 Mn 4.33 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.24 Mn
Mar 31, 2026 -3.34 Mn
Dec 31, 2025 520,729.00
Sep 30, 2025 371,047.00
Jun 30, 2025 -87,471.00
Mar 31, 2025 -10.50 Mn
Dec 31, 2024 3.77 Mn
Sep 30, 2024 -1.92 Mn
Jun 30, 2024 -14.16 Mn
Mar 31, 2024 429,384.00
Dec 31, 2023 -72,946.00
Sep 30, 2023 -4.06 Mn
Jun 30, 2023 -3.87 Mn
Mar 31, 2023 990,972.00
Dec 31, 2022 3.07 Mn
Sep 30, 2022 5.39 Mn
Jun 30, 2022 -3.64 Mn
Mar 31, 2022 7.62 Mn
Dec 31, 2021 11.69 Mn
Sep 30, 2021 6.52 Mn